A Next Generation Scrambler

Conceptual Overview   –   Existing Scrambler Dynamics  –  Scrambler Power Dynamics

Below is a conceptual design envelope — not a build recipe — for a learning-first stimulation system tuned specifically to CRPS, where the objective is threat deconditioning and agency recovery, not forced activation.

This is framed at the level of control logic, safety constraints, and learning semantics, not circuitry or assembly.

1. Primary design goal (non-negotiable)

Train the nervous system to reclassify sensation from threat → governable signal.

Everything else (current, voltage, timing) is subordinate.

If a choice improves contraction but worsens agency, it is wrong for CRPS.

2. The core inversion (vs conventional NMES)

Conventional NMES logic

  • Target current
  • Override impedance
  • Enforce contraction
  • Patient adapts after

Learning-first logic

  • Target prediction
  • Respect impedance
  • Invite sensation
  • Patient adapts before

This single inversion changes the entire envelope.

3. Electrical envelope (high level, not procedural)

Current (biological “dose”)

  • Ultra-low to low range
  • Think: clearly perceivable, never compelling
  • Goal: sensation without urgency

Rule:

The patient must always feel they could tolerate more, even if they choose not to.

This preserves voluntary control.

Voltage (compliance, not stimulus)

  • Sufficient to traverse high, variable skin impedance
  • But never allowed to spike abruptly
  • Voltage is subservient to ramp rules

Rule:

Voltage may rise only as fast as prediction can track.

Impedance (treated as information, not noise)

Instead of “pushing through” impedance:

  • High impedance = system not ready
  • Rapid impedance change = learning event
  • Asymmetry between sides = mapping opportunity

Rule:

Impedance gates permission to increase intensity.

If impedance rises unexpectedly, the system backs off automatically.

4. Temporal envelope (this is where learning lives)

Ramp rate (most critical variable)

  • Extremely slow initial ramps
  • No step changes
  • No surprise onset

Rule:

If the patient can’t predict the next 2–3 seconds of sensation, the ramp is too fast.

This is not about comfort — it’s about cortical inference.

Duration

  • Short exposures early
  • End before fatigue, irritation, or doubt

Rule:

Stop while confidence is rising, not when tolerance is tested.

Frequency of sessions

  • Frequent, brief, predictable
  • Same context, same sequence, same rules

Rule:

Repetition builds safety only when controllability is invariant.

5. Agency architecture (the non-electrical core)

A learning-first system must encode five layers of agency, in order:

  1. Preview – “What will happen”
  2. Invite – “I choose to begin”
  3. Modulate – “I can turn this up/down”
  4. Veto – “I can stop instantly”
  5. Reflect – “Nothing bad followed”

No amount of waveform sophistication compensates for missing layer #4.

6. Threat-avoidance constraints (hard boundaries)

The system must never:

  • Initiate stimulation autonomously
  • Increase intensity without consent
  • Maintain output during rising distress
  • “Push through” resistance
  • Frame discomfort as progress

These are threat-training behaviors, even at low power.

7. Learning signals to privilege (instead of contraction)

Success is measured by:

  • Faster impedance settling
  • Reduced anticipatory guarding
  • Decreased startle at onset
  • Increased willingness to explore
  • Voluntary engagement

Failure looks like:

  • Bracing
  • Dissociation
  • Urge to endure
  • “Let’s just get it over with”

8. Phase structure (implicit, not enforced)

Phase 1 – Safety reacquisition

  • Sensation only
  • No motor goal
  • Full control
  • Terminate early

Phase 2 – Predictive stability

  • Slightly richer sensation
  • Still optional
  • Patient initiates changes

Phase 3 – Voluntary recruitment

  • Movement invited, not caused
  • Stimulation supports action, doesn’t replace it

Phase 4 – Intensity tolerance (optional)

  • Only after the system expects success
  • High amplitude becomes mastery, not exposure

9. Why this works in CRPS terms

CRPS is not cured by “normalizing signals.”
It is relieved when the system relearns:

“I can experience sensation here without losing control.”

Electrical stimulation becomes useful only when it:

  • reduces uncertainty
  • increases authorship
  • restores trust in prediction

10. One-sentence design doctrine

In CRPS, stimulation should never demonstrate power over the body — only return power to the learner.


Existing Scrambler Dynamics


Scrambler Power Dynamics

If we set aside the “information / scrambling” claim and look at Scrambler Therapy devices as electrical delivery systems into human skin, the power story is surprisingly plain: they’re multi-channel, isolated, current-regulated stimulators that assume a wide, skin-dominated impedance and keep average power low.

What the OEM docs imply about volts, amps, and ohms

1) They are current-regulated (not voltage-regulated)

In the FDA 510(k) summary for the ST-5A, the side-by-side comparison explicitly lists “Regulated Current or Regulated Voltage? — current” for both ST-5A and its predicate MC-5A. FDA Access Data

That means the device is trying to achieve a target current, and will raise voltage as needed until it hits its compliance limit.

2) MC-5A (aka “Calmare”) published output envelope: ~12–24 mA p-p, ~12–119 V p-p

The MC-5A user manual specs that are widely mirrored in secondary references report:

  • Output voltage range: 11.875–118.75 V p-p
  • Output current range: 11.875–23.78 mA p-p calmarett.com+1

You can treat that as the electrical “box” the device is designed to operate within.

3) Implied impedance assumptions (Ohm’s law inference)

If a device is current-regulated with a max voltage compliance, then its assumed load range is roughly:

  • Low end: 11.875 V / 23.78 mA ≈ 500 ohms
  • High end: 118.75 V / 11.875 mA ≈ 10,000 ohms

So the MC-5A envelope implicitly assumes something like:

~0.5 kΩ to ~10 kΩ electrode-to-electrode impedance

That’s exactly the range you’d expect for pre-gelled ECG electrodes on real skin, varying by hydration, placement, hair, callus, inflammation, and time-under-stim.

4) ST-5A appears to be a lower-current generation (mA, not tens of mA)

Multiple Scrambler Therapy OEM/affiliated sources describe ST-5A output as “low-intensity” and give a max current around 5 mA:

  • ST-team site: “5 channels … max. 5 mA” st-team.eu+1
  • A Pain Physician review reports average amperage “does not exceed” ~5.5 mA even at high setting. Pain Physician

The FDA 510(k) summary describes “low-intensity stimuli” but doesn’t surface the exact mA number in the excerpted lines we pulled; it does confirm current regulation and the 5-channel, isolated design. FDA Access Data

The “power dynamics” takeaway (for thinking about making your own tools)

A) Voltage is “compliance,” current is the “dose”

  • Current is what drives nerve/muscle activation (and pain/paresthesia).
  • Voltage is mostly the device’s ability to force that current through whatever impedance the skin presents.

Scrambler-style devices, judged purely electrically, look like they’re built to:

  • tolerate high, variable skin impedance (hence high compliance voltage),
  • while keeping current relatively low (mA to tens of mA, depending on generation).

B) The real resistor is the skin–electrode interface

These systems “assume” (because biology forces it) that most impedance is:

  • stratum corneum + gel + contact quality,
    not deep tissue.

So the design problem becomes: avoid nasty current density at the skin while still delivering a perceivable signal.

C) Multi-channel + isolation is part of the safety/performance concept

ST-5A/MC-5A are 5-channel devices and the FDA summary notes transformer isolation per channel. FDA Access Data
That choice is less about “scrambling” and more about:

  • reducing leakage paths,
  • keeping channels independent,
  • managing risk when multiple electrode pairs are on the body.

Why this maps directly onto CRPS learning vs threat signaling

In CRPS terms, the threat lever is usually not raw wattage; it’s:

  • abruptness,
  • unpredictability,
  • localized “hot spots” from high impedance/contact issues,
  • loss of agency.

A current-regulated system with high voltage compliance can still feel like an assault if the interface impedance is high (dry pad, edge lift, bony area), because the device may ramp voltage to maintain current, producing sharp, focal sensations (high current density at edges) long before anything “deep” happens.

 

Scroll to Top